Cardiac Troponin I (TNNI3) (NM_000363) Human Recombinant Protein
产品名称: Cardiac Troponin I (TNNI3) (NM_000363) Human Recombinant Protein
英文名称: Cardiac Troponin I (TNNI3) (NM_000363) Human Recombinant Protein
产品编号: PH36070M5
产品价格: 0
产品产地: 美国
品牌商标: Leading Biology
更新时间: null
使用范围: null
安诺伦(北京)生物科技有限公司
- 联系人 :
- 地址 : 北京大兴经济技术开发区天骥智谷35A
- 邮编 :
- 所在区域 : 北京
- 电话 : 189****2642 点击查看
- 传真 : 点击查看
- 邮箱 : 3359689365@qq.com
产品概述:Recombinant protein of human troponin I type 3 (cardiac) (TNNI3) 蛋白长度:Recombinant protein was produced with GoldORF clone, [GH44360V]. Click on the GoldORF clone link to view cDNA and protein sequences. 表达系统:HEK293T 种属:Human 标签类型:C-Myc/DDK 分子量:23.8 kDa 通用名:TNNI3 总结:Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM). Troponin I is useful in making a diagnosis of heart failure, and of ischemic heart disease. An elevated level of troponin is also now used as indicator of acute myocardial injury in patients hospitalized with moderate/severe Coronavirus Disease 2019 (COVID-19). Such elevation has also been associated with higher risk of mortality in cardiovascular disease patients hospitalized due to COVID-19. [provided by RefSeq, Aug 2020] 形式:Liquid 浓度:>50 ug/mL as determined by microplate BCA method 纯度:> 80% as determined by SDS-PAGE and Coomassie blue staining 储存溶液:25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol 别名:CMD1FF; CMD2A; CMH7; cTnI; RCM1; TNNC1